Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2015-04-20 Major Shareholding Noti…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is a formal notification titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' concerning 'The Diverse Income Trust Plc' and a change in its holding in 'Bioventix Plc'. It details the acquisition or disposal of voting rights, specifying the previous and resulting number of shares and the resulting percentage (8.20%). This structure perfectly matches the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing regulatory thresholds. The appropriate code is MRQ.
2015-04-20 English
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is a formal notification titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' concerning Bioventix plc. It details changes in voting rights and shareholdings by a specific entity (Henderson Global Investors), crossing ownership thresholds (Below 17% & 16%). This structure and content precisely match the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing defined thresholds.
2015-04-20 English
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a short press release from Bioventix plc, dated April 17, 2015, announcing a change in the beneficial holding of a person named Adrian Williams. The text explicitly states that a director/insider now holds a specific percentage (4.85%) of the company's shares. This directly corresponds to the definition of a Director's Dealing or Insider Transaction report, which is classified as 'DIRS' (Director's Dealing). The document length is short (2161 chars), but the content is the primary notification itself, not an announcement of a separate report.
2015-04-17 English
BIOVENTIX PLC - Director Dealing
Director's Dealing Classification · 100% confidence The document explicitly states "BIOVENTIX PLC - Director Dealing" in the title. The content details a transaction (Disposal) involving shares by a director (Peter Harrison, Chief Executive) and provides the number of shares, price, and resulting holding percentage. This directly matches the definition for Director's Dealing.
2015-04-17 English
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is a formal notification titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' concerning 'The Diverse Income Trust Plc' and 'Bioventix Plc'. It details changes in share ownership, specifically crossing a threshold related to voting rights (falling below 11%). This structure and content are characteristic of regulatory filings reporting significant changes in shareholdings by major investors or insiders. This aligns precisely with the definition for Major Shareholding Notification (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific disclosure about share ownership changes.
2015-04-15 English
BIOVENTIX PLC - Final Results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2014' for Bioventix plc. It contains comprehensive financial statements, including a Profit and Loss Account, Balance Sheet, and Cash Flow Statement, along with detailed notes to the financial information. Since it covers a period shorter than a full fiscal year and includes substantive financial data, it is classified as an Interim/Quarterly Report. H1 2014
2015-03-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.